| Patient # |
Hematological disease |
| 1 |
ALL |
| 2 |
AML |
| 3 |
AML |
| 4 |
AML |
| 5 |
AML |
| 6 |
AML |
| 7 |
AML |
| 8 |
AML |
| 9 |
AML |
| 10 |
AML |
| 11 |
AML |
| 12 |
BAL |
| 13 |
CML |
| 14 |
Hodgkin lymphoma |
| 15 |
Hodgkin lymphoma |
| 16 |
Hodgkin lymphoma |
| 17 |
MDS & MPS |
| 18 |
Multiple myeloma |
| 19 |
Multiple myeloma |
| 20 |
Multiple myeloma |
| 21 |
MDS |
| 22 |
MDS |
| 23 |
MDS |
| 24 |
MDS |
| 25 |
MDS |
| 26 |
MDS |
| 27 |
MDS |
| 28 |
NHL |
| 29 |
NHL |
| 30 |
NHL |
| 31 |
NHL |
| 32 |
Secondary acute leukemia |
|
| Abbreviations: ALL:Acute Lymphoid Leukemia; AML:Acute Myeloid Leukemia;BAL:Biphenotypic Acute Leukemia; CML:Chronic Myeloid Leukemia;
MDS:Myelo-dysplastic Syndrome; MPS:MyeloproliferativeSyndrome; NHL: Non-Hodgkin Lymphoma |
| Table 3f: Clinico-pathological characteristics of patients with hematological
malignancies. |
